As for 1-month mortality in validation cohort, GCS (p < 0.001), hematoma volume (p < 0.001), presence of IVH (p < 0.001) and HE (p = 0.002), platelet count (PLT) (p = 0.036), prothrombin time (PT) (p = 0.006), international normalized ratio (INR) (p = 0.018), NLR (p < 0.001), fibrinogen (p < 0.001), and F-NLR score (p < 0.001) were risk factors in univariate analysis. The gene discussed is F2; the disease is hematoma.